333 related articles for article (PubMed ID: 22850020)
21. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
22. Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challenges.
Thompson R; Drew CJ; Thomas RH
Adv Protein Chem Struct Biol; 2012; 89():27-63. PubMed ID: 23046881
[TBL] [Abstract][Full Text] [Related]
23. Exome sequencing explained: a practical guide to its clinical application.
Seaby EG; Pengelly RJ; Ennis S
Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
[TBL] [Abstract][Full Text] [Related]
24. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.
Strom SP; Lee H; Das K; Vilain E; Nelson SF; Grody WW; Deignan JL
Genet Med; 2014 Jul; 16(7):510-5. PubMed ID: 24406459
[TBL] [Abstract][Full Text] [Related]
25. Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing.
Diekstra A; Bosgoed E; Rikken A; van Lier B; Kamsteeg EJ; Tychon M; Derks RC; van Soest RA; Mensenkamp AR; Scheffer H; Neveling K; Nelen MR
Clin Chem; 2015 Jan; 61(1):154-62. PubMed ID: 25274553
[TBL] [Abstract][Full Text] [Related]
26. Clinical exome sequencing – Norwegian findings.
Holla ØL; Busk ØL; Tveten K; Hilmarsen HT; Strand L; Høyer H; Bakken A; Skjelbred CF; Braathen GJ
Tidsskr Nor Laegeforen; 2015 Nov; 135(20):1833-7. PubMed ID: 26534809
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing: a transient technology for molecular diagnostics?
Ku CS; Cooper DN
Expert Rev Mol Diagn; 2012 Apr; 12(3):211-4. PubMed ID: 22468808
[No Abstract] [Full Text] [Related]
28. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
Ku CS; Cooper DN; Iacopetta B; Roukos DH
Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
[TBL] [Abstract][Full Text] [Related]
29. Exome versus transcriptome sequencing in identifying coding region variants.
Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
[TBL] [Abstract][Full Text] [Related]
30. Application of next generation sequencing to molecular diagnosis of inherited diseases.
Zhang W; Cui H; Wong LJ
Top Curr Chem; 2014; 336():19-45. PubMed ID: 22576358
[TBL] [Abstract][Full Text] [Related]
31. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
Smith A; Boycott KM; Jarinova O
Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
[TBL] [Abstract][Full Text] [Related]
32. Next-generation sequencing - feasibility and practicality in haematology.
Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
[TBL] [Abstract][Full Text] [Related]
33. Progress in detecting genetic alterations and their association with human disease.
Schwartz CE; Chen CF
J Mol Biol; 2013 Nov; 425(21):3914-8. PubMed ID: 23876707
[TBL] [Abstract][Full Text] [Related]
34. Orthogonal NGS for High Throughput Clinical Diagnostics.
Chennagiri N; White EJ; Frieden A; Lopez E; Lieber DS; Nikiforov A; Ross T; Batorsky R; Hansen S; Lip V; Luquette LJ; Mauceli E; Margulies D; Milos PM; Napolitano N; Nizzari MM; Yu T; Thompson JF
Sci Rep; 2016 Apr; 6():24650. PubMed ID: 27090146
[TBL] [Abstract][Full Text] [Related]
35. Clinical exome sequencing-Mistakes and caveats.
Corominas J; Smeekens SP; Nelen MR; Yntema HG; Kamsteeg EJ; Pfundt R; Gilissen C
Hum Mutat; 2022 Aug; 43(8):1041-1055. PubMed ID: 35191116
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
[TBL] [Abstract][Full Text] [Related]
37. Evolution of DNA sequencing.
Tipu HN; Shabbir A
J Coll Physicians Surg Pak; 2015 Mar; 25(3):210-5. PubMed ID: 25772964
[TBL] [Abstract][Full Text] [Related]
38. The Rise and Rise of Exome Sequencing.
Ku CS; Cooper DN; Patrinos GP
Public Health Genomics; 2016; 19(6):315-324. PubMed ID: 27898412
[TBL] [Abstract][Full Text] [Related]
39. Clinical sequencing: is WGS the better WES?
Meienberg J; Bruggmann R; Oexle K; Matyas G
Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
[TBL] [Abstract][Full Text] [Related]
40. Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases.
Punetha J; Kesari A; Uapinyoying P; Giri M; Clarke NF; Waddell LB; North KN; Ghaoui R; O'Grady GL; Oates EC; Sandaradura SA; Bönnemann CG; Donkervoort S; Plotz PH; Smith EC; Tesi-Rocha C; Bertorini TE; Tarnopolsky MA; Reitter B; Hausmanowa-Petrusewicz I; Hoffman EP
J Neuromuscul Dis; 2016 May; 3(2):209-225. PubMed ID: 27854218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
